Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2012, 13(11), 14326-14343; doi:10.3390/ijms131114326
Article

Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin

1
, 1
, 1
, 1
, 2
, 3
 and 1,2,*
Received: 3 September 2012; in revised form: 29 October 2012 / Accepted: 30 October 2012 / Published: 6 November 2012
(This article belongs to the Section Biochemistry, Molecular Biology and Biophysics)
View Full-Text   |   Download PDF [1721 KB, updated 19 June 2014; original version uploaded 19 June 2014]
Abstract: Calsequestrin (CASQ) is a major Ca2+-storage/buffer protein present in the sarcoplasmic reticulum of both skeletal (CASQ1) and cardiac (CASQ2) muscles. CASQ has significant affinity for a number of pharmaceutical drugs with known muscular toxicities. Our approach, with in silico molecular docking, single crystal X-ray diffraction, and isothermal titration calorimetry (ITC), identified three distinct binding pockets on the surface of CASQ2, which overlap with 2-methyl-2,4-pentanediol (MPD) binding sites observed in the crystal structure. Those three receptor sites based on canine CASQ1 crystal structure gave a high correlation (R2 = 0.80) to our ITC data. Daunomycin, doxorubicin, thioridazine, and trifluoperazine showed strong affinity to the S1 site, which is a central cavity formed between three domains of CASQ2. Some of the moderate-affinity drugs and some high-affinity drugs like amlodipine and verapamil displayed their binding into S2 sites, which are the thioredoxin-like fold present in each CASQ domain. Docking predictions combined with dissociation constants imply that presence of large aromatic cores and less flexible functional groups determines the strength of binding affinity to CASQ. In addition, the predicted binding pockets for both caffeine and epigallocatechin overlapped with the S1 and S2 sites, suggesting competitive inhibition by these natural compounds as a plausible explanation for their antagonistic effects on cardiotoxic side effects.
Keywords: CASQ; calsequestrin; SR; sarcoplasmic reticulum; CASQ2; cardiac calsequestrin; CASQ1; skeletal calsequestrin; TFP; trifluoperazine; ITC; isothermal titration calorimetry; daunomycin; DAN; desipramine; DSP; diltiazem; DTZ; propafenone; PFN; thioridazine; TDZ CASQ; calsequestrin; SR; sarcoplasmic reticulum; CASQ2; cardiac calsequestrin; CASQ1; skeletal calsequestrin; TFP; trifluoperazine; ITC; isothermal titration calorimetry; daunomycin; DAN; desipramine; DSP; diltiazem; DTZ; propafenone; PFN; thioridazine; TDZ
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Subra, A.K.; Nissen, M.S.; Lewis, K.M.; Muralidharan, A.K.; Sanchez, E.J.; Milting, H.; Kang, C. Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin. Int. J. Mol. Sci. 2012, 13, 14326-14343.

AMA Style

Subra AK, Nissen MS, Lewis KM, Muralidharan AK, Sanchez EJ, Milting H, Kang C. Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin. International Journal of Molecular Sciences. 2012; 13(11):14326-14343.

Chicago/Turabian Style

Subra, Arun K.; Nissen, Mark S.; Lewis, Kevin M.; Muralidharan, Ashwin K.; Sanchez, Emiliano J.; Milting, Hendrik; Kang, ChulHee. 2012. "Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin." Int. J. Mol. Sci. 13, no. 11: 14326-14343.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert